Apical Ballooning Syndrome
Transcript of Apical Ballooning Syndrome
-
8/4/2019 Apical Ballooning Syndrome
1/33
Transient Left VentricularTransient Left Ventricular
Apical Ballooning SyndromeApical Ballooning Syndrome
TakoTako--Tsubo / AmpullaTsubo / Ampulla
CardiomyopathyCardiomyopathy
-
8/4/2019 Apical Ballooning Syndrome
2/33
CharacteristicsCharacteristics First described in 1991 by Sato & Dote et al in Japanese literatureFirst described in 1991 by Sato & Dote et al in Japanese literature
AnginaAngina
ST segment elevation / diffuse T wave inversion / abnormal Q wavesST segment elevation / diffuse T wave inversion / abnormal Q waves
RWMA in lower anterior wall and apexRWMA in lower anterior wall and apex
Myocardial enzyme release (mild to mod.)Myocardial enzyme release (mild to mod.)
Hemodynamically insignificant stenosis on CAGHemodynamically insignificant stenosis on CAG
Psychological / physical stress within minutes to hours of onset ofPsychological / physical stress within minutes to hours of onset ofsymptomssymptoms
Hemodynamic compromise, cardiac arrestHemodynamic compromise, cardiac arrest
Rapid resolution of RWMA & normalization of EF in 7Rapid resolution of RWMA & normalization of EF in 7--30 days30 days
-
8/4/2019 Apical Ballooning Syndrome
3/33
Systematic Review of 7 case seriesSystematic Review of 7 case seriesAnn Intern Med 2004
Demographics and Presenting Symptoms
82% to 100% were women
Mean age was 62 to 75 years
Presenting symptom chest pain (33% to 71%)
Dyspnea & rarely syncope
-
8/4/2019 Apical Ballooning Syndrome
4/33
ECG findings on admission
ST-segment elevation (46% to 100%)
Mostly precordial leads and more marked in V4-V6
Isolated inferior or lateral ST elevation unusual
New LBBB and RBBB
Almost all patients developed T-wave inversions usually present inmost leads.
New pathologic Q waves (6% to 31%)
The corrected QT interval (mean 0.45 s to 0.50 s)
Systematic ReviewSystematic Review
-
8/4/2019 Apical Ballooning Syndrome
5/33
Cardiac Enzyme and Biomarker Release
Most patients had a modest increase in cardiac enzyme levels.
56% incidence of increase in creatine kinase
100% incidence of increase in cardiac troponin
Peak levels are often those drawn at the time of initial
presentation
Do not follow the kinetics observed with conventional MI.
Systematic ReviewSystematic Review
-
8/4/2019 Apical Ballooning Syndrome
6/33
Angiographic Data and LV Function
No angiographically detectable lesion(25% to 100%)
Nonobstructive coronary disease (0% to 75%)
None of the patients had epicardial stenosis greater than 50%
Mean LVEF at presentation 0.39 to 0.49
LVEF improved rapidly over a period of days to weeks to mean0.60 to 0.76
Apical and mid-ventricular RWMA completely resolved in mostpatients
Systematic ReviewSystematic Review
-
8/4/2019 Apical Ballooning Syndrome
7/33
Endothelial Function and Coronary Microcirculation
Either spontaneous or provocable multivessel epicardial spasmwas present in 0% to 43%
Coronary flow reserve (coronary microvascular function)showed conflicting results
Abnormal TIMI frame counts in all 3 major epicardial coronary
arteries during the acute phase of the syndrome
Systematic ReviewSystematic Review
-
8/4/2019 Apical Ballooning Syndrome
8/33
Clinical Complications and Outcome n-hospital mortality rates - 0% to 8%
Significant LV failure during the acute phase in 3% to 46%
A transient, dynamic intraventricular pressure gradient due toobstruction in the LV cavity in 13% to 18% with MR
AV block, sinus bradycardia, paroxysmal atrial fibrillation, VT and Vfib
Isolated cases of LV mural thrombus formation
1 case of LV freewall rupture occurred 3 days after presentation
Cardiogenic shock
Death
Systematic ReviewSystematic Review
-
8/4/2019 Apical Ballooning Syndrome
9/33
Preceding Stressors, Incidence, and Recurrence
Most patients presented immediately after an episode of acute
emotional (14% to 38%) or physiologic (17% to 77%)
In 1 series, this syndrome represented 2.2% of ST elevation
ACS presenting to a referral hospital during 2002 and 2003
A separate series, this syndrome was diagnosed in 1.5% of
patients who had presented with an Qwave ACS
Recurrence of the syndrome seems to be rare (0% to 8%)
Systematic ReviewSystematic Review
-
8/4/2019 Apical Ballooning Syndrome
10/33
Possible triggering factorsPossible triggering factors
Systemic disordersSystemic disorders
CVACVA
epileptic attacksepileptic attacks
exacerbation of bronchialexacerbation of bronchialasthmaasthma
acute abdomenacute abdomen
noncardiac surgery/procedurenoncardiac surgery/procedure
PnuemothoraxPnuemothorax
Emotional/physical problemsEmotional/physical problems
death/funeral of family memberdeath/funeral of family member
Surprise party / reunionSurprise party / reunion
fear of procedurefear of procedure
public speakingpublic speaking
court appearancecourt appearance
tragic newstragic news
sudden accidentssudden accidentsinexperienced exerciseinexperienced exercise
quarrelingquarreling
excessive alcohol consumptionexcessive alcohol consumption
vigorous excitationvigorous excitation
-
8/4/2019 Apical Ballooning Syndrome
11/33
MechanismMechanism Several mechanisms have been proposed
Catecholamines mediated myocardial stunning
neurogenically mediated
direct metabolic injury
multivessel epicardial spasm
microvascular coronary spasm/dysfunction
Abnormal LAD anatomy
Intraventricular gradient
Genetic
-
8/4/2019 Apical Ballooning Syndrome
12/33
Neurogenic
Acute mental stress, a time of enhanced sympathetic outflow
The distribution of apical WMA is similar to the distribution reportedwith catecholamine-induced cardiomyopathy (pheochromocytoma,
GBS, SAH)
Increased adrenergic receptor density and responsiveness in theapical segments
In a rat model the RWMA could not be reproduced after pretreatmentwith adrenoreceptor antagonist
Measurements of circulating catecholamine levels have showninconsistent results suggesting that activation of cardiacadrenoceptors maybe the primary cause.
-
8/4/2019 Apical Ballooning Syndrome
13/33
Direct metabolic injury
Elevated catecholamine level decrease the viability of myocytesthrough cAMPmediated calcium overload and formation of freeradicals causing necrosis
Transient exposure to excessive catecholamines, may resultin stunning with cellular metabolic abnormalities rather than necrosis
Pulmonary sympathetic stimulation increases the pore size in thepulmonary capillaries, leading to alveolar transudation
Studies have demonstrated a reduction of the fatty acid metabolismand mitochondrial function in the apical myocardium by usingisotopes, suggesting direct myocardial toxicity
-
8/4/2019 Apical Ballooning Syndrome
14/33
Coronary spasmCoronary spasm
In an angiographic studies,
spontaneous spasm seen very occasionally
70 % had coronary spasm (single/multivessel) in response to
provocative maneuvers (ergonovine or acetylcholine)
ST elevation was common at presentation
Multivessel coronary vasospasm (which could probably produce
diffuse wall-motion abnormalities), was found in 18% patients testedacross series
Transient multivessel epicardial spasm may be responsible for some
cases of the syndrome
-
8/4/2019 Apical Ballooning Syndrome
15/33
Microcirculatory spasm/dysfunctionMicrocirculatory spasm/dysfunction
Coronary microvascular function has been shown to be diffuselyabnormal when assessed using CFR and TIMI frame counts
IC nicorandil during the acute phase acutely reduced the extent
of ST elevation
Regional defects on cardiac imaging suggests sympatheticallymediated microcirculatory dysfunction.
? primary mechanism or secondary phenomenon
-
8/4/2019 Apical Ballooning Syndrome
16/33
Abnormal LAD anatomyAbnormal LAD anatomy
In a series of 5 tako-tsubo patients,the LAD had a long course around the LV apex, supplying an
extensive portion of the diaphragmatic LV aspect
Transient coronary artery occlusion/reperfusion episodes may lead tostunning and akinesia also the minimal release of biomarkers withtotal recovery of cardiac function
Pathogenesis of this disorder could be similar to that of AMI:
coronary atherosclerotic plaque complicated by thrombotic occlusion
Evidence supporting the hypothesis is weak and hardly explainscharacteristics of this syndrome
-
8/4/2019 Apical Ballooning Syndrome
17/33
ntraventricular gradientIntraventricular gradient
Clinical and hemodynamic situation improved when the gradientdisappeared and in some cardiogenic shock persisted until thedynamic obstruction was present
Dynamic obstruction raise intraventricular pressures in the distal
chamber and reduce myocardial perfusion, leading to ischemia anddyskinesia
Exposure to an exogenous catecholamine (dobutamine), can provokedynamic LVOT obstruction even in normal hearts
Some women might have a geometric predisposition (sigmoidseptum, narrow LVOT, reduced LV volume) to the development ofdynamic subaortic obstruction that would only manifest with intenseadrenergic stimulation
-
8/4/2019 Apical Ballooning Syndrome
18/33
Proposed pathophysiologicalmechanism of TLVABS
-
8/4/2019 Apical Ballooning Syndrome
19/33
Female PreponderanceFemale Preponderance
Sex hormones exert important influences on the sympatheticneurohormonal axis as well as on coronary vasoreactivity.
Women are more vulnerable to sympathetically mediated myocardialstunning (transient LV dysfunction after SAH)
Explanation - alterations of endothelial function and microcirculatoryvasomotor reactivity due to reduced estrogen levels
Estradiol supplementation attenuates emotional stressinducedchanges in LV function in ovariectomized female rats.
-
8/4/2019 Apical Ballooning Syndrome
20/33
PATHOLOGICAL FINDINGS
Interstitial fibrosis was a common finding and no significant
inflammation necrosis during the acute phase
Later myocytolysis, with cell infiltrates including mononuclear
cells and increase of loose connective tissue.
The histologic findings in this heart syndrome, were similar toThe histologic findings in this heart syndrome, were similar to
those observed in catecholaminethose observed in catecholamine--induced cardiomyopathyinduced cardiomyopathy
There was no evidence of acute myocarditis in any series.
-
8/4/2019 Apical Ballooning Syndrome
21/33
Proposed Mayo Criteria for the ClinicalDiagnosis
1. Transient akinesis or dyskinesis of the left ventricular apical and mid-ventricular segments with regional wall-motion abnormalities extendingbeyond a single epicardial vascular distribution
2. Absence of obstructive coronary disease or angiographic evidence of acute
plaque rupture
3. New electrocardiographic abnormalities (either ST-segment elevation or Twave inversion)
4. Absence ofRecent significant head traumaIntracranial bleedingPheochromocytomaObstructive epicardial coronary artery diseaseMyocarditis
Hypertrophic cardiomyopathy * All 4 criteria must be met
-
8/4/2019 Apical Ballooning Syndrome
22/33
Diagnosis of TLVABS Prior conditions (both obligatory):
Evidence of transient apical dysfunction of LV with a typical shape inthe systole, diagnosed by angio, echo, isotopes, or cardiac MRI. Normalventricular mobility returns in 2-3 weeks
Absence of other conditions associated with transient regional systolicdysfunction of the LV: SAH, pheochromocytoma, cardiac ischemia, toxicsubstances (cocaine), myocarditis, etc.
Diagnostic CriteriaMajorcriteria
Early coronary angiography (first24 h) withoutanatomical lesions
Minorcriteria1. Early coronary angiography with non-significant lesions2. Late coronary angiography(2 to7 days) withoutsignificant lesions3. Disordertriggered by physical oremotional stress4. Typical ECG changes ST segmentelevation in acute phase, Q waves
thatdisappearafteracute phase, T inversion prominentin V1-V6
and prolongation of QTc5. Woman aged >50 years
-
8/4/2019 Apical Ballooning Syndrome
23/33
ManagementManagement Beta-blockers
ACEI (in patients without an intracavitary gradient)AspirinIV diuretics
Pts with hypotension must be evaluated for a dynamic intraventricularpressure gradient in the LV cavity and LVOT which is managed by
beta-blockers,phenylephrinefluid resuscitation
Beta-blockers and phenylephrine are not recommended in documentedepicardial coronary vasospasm (diltiazem or verapamil)
Short-term anticoagulation if significant LV dysfunction and continued untilLV function has improved
Monitoring for atrial and ventricular arrhythmias, heart failure, andmechanical complications.
-
8/4/2019 Apical Ballooning Syndrome
24/33
69-year-old womanacute chest pain
CPKMB was elevatedurgent CAG - normal coronaries
LV angio-apical ballooning insystole
LVEF of 33% & severe MRMidcavity gradient of 25
mmHg
Supportive therapyClinical recovery within 1 weekLV function normal at 40 days
-
8/4/2019 Apical Ballooning Syndrome
25/33
8080--yearyear
--old woman withold woman withhypertensionhypertension
33--hour history of dyspnoea andhour history of dyspnoea andprecordial discomfortprecordial discomfort
trop T, CPK and CPKtrop T, CPK and CPK--MB wereMB werenormalnormal
patient developed haemodynamicpatient developed haemodynamicinstability, cardiac cath was doneinstability, cardiac cath was done
The patients condition improvedThe patients condition improvedafterafter an IABP was placedan IABP was placed
Echo 3Echo 3 weeks later showedweeks later showednormal LV size and function.normal LV size and function.
-
8/4/2019 Apical Ballooning Syndrome
26/33
78-year-old woman withhypertension
acute epigastric pain since 12hours
melena and Hb of8g/L.
After transfusion of 2 units ofpacked RBCs, the symptomsdisappeared and the ECGevidenced extensive anteriorsubepicardial ischemia.
The trop I was 8.5 ng/mL.
Echo showed anteroapicalakinesia and dynamicsubaortic obstruction with apeak gradient of 42 mm Hg
Cath performed 5 days latershowed normal coronariesand apical ballooning
She has remainedasymptomatic after 15 monthsof follow-up, with normalizedECG and LV wall motion
-
8/4/2019 Apical Ballooning Syndrome
27/33
64 year old woman
No coronary risk factors
continuous atypical chest pain-2d
Maximal CPK and trop I valueswere 159 U/l (normal 0170) and7.4 ng/ml (00.1)
CAG-normal coronaries
LV angio - apical ballooning, apicalthrombus. LVEF 40%. Confirmedwith TTE (IV gradient 75mmHg)
Pathologic Q waves developedfrom V1-V3
discharged under anticoagulants
3 months later T in V3V6TTE - normal LVwall motion, LVEF62%, complete resolution of theapical thrombus and IV pressuregradient
Apical thrombus in TLVABSApical thrombus in TLVABS
-
8/4/2019 Apical Ballooning Syndrome
28/33
Indian Heart JournalIndian Heart Journal
5 cases (all females) aged 225 cases (all females) aged 2240 years40 years
Presenting with severe transient LV dysfunction, and cardiogenicPresenting with severe transient LV dysfunction, and cardiogenic
shock following surgery (cesarean section 2, laparoscopicshock following surgery (cesarean section 2, laparoscopic
cholecystectomy 3)cholecystectomy 3)
All the patients had ECG changes in multiple leads, suggestive ofAll the patients had ECG changes in multiple leads, suggestive of
STEMI in 2 cases, and NSTE MI in 3 cases, raised cardiac enzymes,STEMI in 2 cases, and NSTE MI in 3 cases, raised cardiac enzymes,
severe LV dysfunction, and normal coronariessevere LV dysfunction, and normal coronaries
IABP support was required in 3 cases.IABP support was required in 3 cases.
All the patients made a complete recovery, and are asymptomatic atAll the patients made a complete recovery, and are asymptomatic at
11--month to 6month to 6--year followyear follow--up.up.
-
8/4/2019 Apical Ballooning Syndrome
29/33
Unanswered QuestionsUnanswered Questions
Why do middleWhy do middle--aged/elderly women appearaged/elderly women appearsusceptible to this disorder?susceptible to this disorder?
Exactly how does psychological stress trigger itsExactly how does psychological stress trigger itssudden onset?sudden onset?
Why is the LV apex selectively vulnerable to regionalWhy is the LV apex selectively vulnerable to regionalballooning?ballooning?
Is this really a new disease with increasing incidence,Is this really a new disease with increasing incidence,or has it previously been unrecognized?or has it previously been unrecognized?
Should pharmacological therapy be continuedShould pharmacological therapy be continued
indefinitely?indefinitely?
-
8/4/2019 Apical Ballooning Syndrome
30/33
Clinical RelevanceClinical Relevance
Although rare, TLVABS must be considered as a d/d ofAlthough rare, TLVABS must be considered as a d/d ofACS or STEMIACS or STEMI
Especially when extent of ECG abnormaliries exceedEspecially when extent of ECG abnormaliries exceedbiomarker evidence for myocardial necrosis and CAGbiomarker evidence for myocardial necrosis and CAG
confirms noncritical CAD.confirms noncritical CAD.
Prompt recognition and aggressive t/tPrompt recognition and aggressive t/t(pharmacological / mechanical)(pharmacological / mechanical)
-
8/4/2019 Apical Ballooning Syndrome
31/33
THANKTHANK YOUYOU
-
8/4/2019 Apical Ballooning Syndrome
32/33
ST-Segment Elevation in Various Conditions
ConditionCondition FeatureFeature
Normal (male pattern)Normal (male pattern) 90 percent of healthy young men
Concave, 13mm, most marked in V2
Early repolarizationEarly repolarization Most marked in V4, notching at J point
Tall, upright T waves
Reciprocal ST depression in aVR
ST elevation normal variantST elevation normal variant V3- V5, inverted T waves
Short QT, high QRS voltage
LVHLVH Concave, Other features of LVH
LBBBLBBB Concave
ST deviation discordant from the QRS
Acute PericarditisAcute Pericarditis Diffuse ST elevation, Reciprocal STdepression in aVR, Elevation
seldom>5mm, PR-segment depression
-
8/4/2019 Apical Ballooning Syndrome
33/33
ConditionCondition FeatureFeature
HyperkalemiaHyperkalemia Other features of hyperkalemia presentOther features of hyperkalemia present
Brugada SyndromeBrugada Syndrome rSR' in V1-2, ST- elevation in V1-2,
typically downsloping
Pulmonary embolismPulmonary embolism Changes simulating MI in both inferior
and anteroseptal leads
CardioversionCardioversion ST elevation, often >10 mm, lasting
only a minute or two immediately after
DC shock
Prinzmetal AnginaPrinzmetal Angina Same as ST-segment elevation in
infarction, but transient